DIRECT CONTACT TREATMENT OF AQUATIC ANIMALS AND OTHER SUBMERGED TARGET BODIES VIA VISCOUS AND HYDROPHOBIC DELIVERY COMPOSITIONS

METHOD OF PROGNOSING AND TREATING GLIOMA

COMPOSITIONS AND THERAPEUTIC METHODS OF MICRORNA GENE DELIVERY

INTRACELLULAR KINASE ASSOCIATED WITH RESISTANCE AGAINST ANTI-TUMOUR IMMUNE RESPONSES, AND USES THEREOF

COMPOSITIONS AND METHODS FOR NUCLEIC ACID TRANSFER

RNA ENGINEERED T CELLS FOR THE TREATMENT OF CANCER

Cancer Treatment comprising an anti-MSLN/CD137 antibody and a chemotherapeutic

METHODS OF TREATING DERMATOMYOSITIS

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS IN IGG4-RELATED DISEASES

CD3 TARGETING ANTIBODIES AND USES THEREOF

SPECIFIC ANTAGONIST ANTI-SIRPg ANTIBODIES

CLDN18.2-TARGETING ANTIBODY, BISPECIFIC ANTIBODY AND USE THEREOF

ANTIGEN TOLERANCE INDUCTION THROUGH USE OF FLT3L VARIANTS

CD73 INHIBITOR COMPOUNDS

SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINES AS BRUTON'S TYROSINE KINASE MODULATORS

GCN2 INHIBITOR (as amended)

COMPOSITIONS COMPRISING (R)-2-AMINO-3-PHENYLPROPYL CARBAMATE AND USES THEREOF

TETRAHYDRO-1H-CYCLOPENTA[CD]INDENE DERIVATIVES AS HYPOXIA INDUCIBLE FACTOR-2(ALPHA) INHIBITORS

COMPOSITIONS AND METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS

Solution Loaded with Alpha-Emitter Radionuclides

RADIOIMMUNOCONJUGATES TARGETING PHOSPHATIDYLSERINE FOR USE IN THE TREATMENT OF CANCER

COMPOSITIONS AND METHODS FOR TREATING CANCER BY INCREASING EXPRESSION OF OBSCN-AS1 LONG-NONCODING RNA

AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE DIFFERENT FUNCTIONAL SMALL MOLECULES FOR ENHANCED TREATMENT OF REFRACTORY DISEASES

STIMULI RESPONSIVE BLOCK COPOLYMERS

METHODS FOR TREATING CANCER WITH ENHANCED ANTIGEN PRESENTING CELLS

COMPOSITIONS AND METHODS FOR USE IN KRAS-TARGETED THERAPIES FOR THE TREATMENT OF CANCER

COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASE

DOSAGE FORMS OF TISSUE KALLIKREIN 1

ORAL OCTREOTIDE FOR THE TREATMENT OF DISEASE

SYSTEMS AND METHODS FOR SYMPATHETIC CARDIOPULMONARY NEUROMODULATION

METHOD OF TREATING OR PREVENTING AN ADVERSE SECONDARY NEUROLOGICAL OUTCOME FOLLOWING A HAEMORRHAGIC STROKE

EXTRACELLULAR VESICLES FROM MICROALGAE, THEIR BIODISTRIBUTION UPON INTRANASAL ADMINISTRATION, AND USES THEREOF

HEPATOPROTECTIVE PROBIOTIC COMPOSITIONS

Mind and Body Healing Synergistic Phytomedical Formulation

COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND FISETIN FOR CELLULAR ENERGY

INHALATION FORMULATIONS CONTAINING NITRIC OXIDE RELEASING COMPOUNDS AND METHODS OF USING SAME

Modulators of Orphan Nuclear Receptors for Treating Pancreatitis, Glioblastoma, Sarcopenia and Stroke

Methods and Compositions for Treating Fatty Liver and Viral Infections

TREATMENT OF CHRONIC COUGH, BREATHLESSNESS AND DYSPNEA

CRYSTALLINE FORMS OF ALDH2 MODULATORS

COMBINATIONS OF MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2 ADRENORECEPTOR AGONIST

METHODS OF TREATING SOLID TUMOR USING (19R)-5-CHLORO-3-ETHYL-16-FLUORO-10,19-DIMETHYL-20-OXA-3,4,10,11,23-PENTAAZAPENTACYCLO[19.3.1.02,6.08,12.013,18]PENTACOSA-1(24),2(6),4,8,11,13,15,17,21(25),22-DECAEN-22-AMINE

COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS

Treatment Method and Product for Uterine Fibroids using Purified Collagenase

BONDED MICROPARTICULATES PREPARATION AND APPLICATIONS THEREOF

METHODS FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

TREATING TUBEROUS SCLEROSIS COMPLEX-ASSOCIATED DISEASES

METHODS AND COMPOSITIONS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE

INDUCIBLE CHIMERIC CYTOKINE RECEPTORS

METHOD FOR PREPARATION OF CYTOTOXIC T LYMPHOCYTES WITH BROAD TUMOUR-SPECIFIC REACTIVITY AND CHARACTERISTICS OF EARLY DIFFERENTIATION CELLS

ANTI-CD137 ANTIBODIES FOR COMBINATION WITH ANTI-PD-1 ANTIBODIES

BINDING AGENTS AND METHODS OF USE THEREOF

ANTIBODIES TO ICOS

CLAUDIN 4 AND CLAUDIN 9 ANTIBODIES AND METHODS OF TREATING CANCER

NOVEL POLYPEPTIDES

TIMOSAPONIN COMPOUNDS

ANTIVIRAL COMPOUNDS

IRAK DEGRADERS AND USES THEREOF

ACETYLATION WRITER INHIBITOR DEVELOPMENT AND USES THEREOF

CERTAIN PLADIENOLIDE COMPOUNDS AND METHODS OF USE

INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES

BENZYLAMIDE DERIVATIVES AS INHIBITORS OF TRANSFORMING GROWTH FACTOR-BETA RECEPTOR I/ALK5

N-OXIDE COMPOUNDS AND USE THEREOF

ENGINEERING SUICIDE GENE APPROACHES TO IMPROVE CHEMOTHERAPEUTIC RESPONSE IN CANCER

FACET-BASED NUCLEIC ACID PLATONIC, KEPLER-POINSOT POLYHEDRA AND FOUR-DIMENSIONAL TESSERACT FOR THERAPEUTIC, DIAGNOSTIC AND ANALYTICAL APPLICATIONS

HYDROGEL FOR IN-VIVO RELEASE OF MEDICATION

BIFUNCTIONAL SMALL MOLECULES TO TARGET THE SELECTIVE DEGRADATION OF CIRCULATING PROTEINS

DRUG DELIVERY

PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES

METHODS FOR TREATING TUMORS

BATCH MANAGEMENT METHOD FOR IMPROVING FARROWING RATE OR NUMBER OF PIGLETS BORN ALIVE IN SWINE

IMMUNE CHECKPOINT INHIBITOR COMBINATIONS

PHARMACEUTICAL COMPOSITION, MEGASPHAERA, AND USE THEREOF

NEOADJUVANT USE OF ANTIBODY-DRUG CONJUGATES

COMPOSITIONS AND METHODS FOR THE STIMULATION OF INTERMEDIATE MACROPHAGES AND TREATMENTS THEREWITH

ANTIBIOTIC METHODS AND COMPOSITIONS

THERAPY AND PREVENTION OF PRION PROTEIN COMPLEX INFECTIONS IN NON-HUMAN ANIMALS

METHODS AND COMPOSITIONS FOR SLEEP DISORDERS AND OTHER DISORDERS

RILUZOLE PRODRUGS AND THEIR USE

PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF CANCER

A PHARMACEUTICAL COMPOSITION COMPRISING AN INHIBITOR OF GLUTAMINE SYNTHETASE ENZYME TO COMBAT ARTEMISININ RESISTANCE IN MALARIA

OPHTHALMIC FORMULATIONS AND METHODS OF USE

PSYCHOACTIVE MEDICINES AND THEIR USE FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS AND DISORDERS

SELENIUM-CONTAINING SUBSTANCE FOR TREATMENT OF CANCER

DENDRON-LIKE LIPID COMPOUND, LIPOSOME, LIPID COMPLEX, AND LIPID NANOPARTICLE AND USE THEREOF

OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR

TOPICAL FORMULATION COMPRISING OMEGA-3 FATTY ACIDS, MELATONIN AND VITAMIN D

SUSTAINED RELEASE COMPOSITIONS

SMALL MOLECULE TREATMENT OF MTRES1 RELATED DISEASES AND DISORDERS

Methods of Expanding Cholangiocytes

Antibody or Fragment Thereof Binding Specifically to Mertk, and Anti-Tumor Agent

ANTI-CANCER ANTIBODIES, COMBINATION THERAPIES, AND USES THEREOF

METHODS OF TREATING CANCER IN IMMUNOSUPPRESSED OR IMMUNOCOMPROMISED PATIENTS BY ADMINISTERING A PD-1 INHIBITOR

BISPECIFIC ANTIBODY COMBINATION AND USE THEREOF

ANTI-TIGIT ANTIBODIES AND METHODS OF USE

COMBINATION THERAPY OF CLAUDIN 18.2 ANTAGONIST AND PD-1/PD-L1 AXIS INHIBITOR

ENGINEERED INTERLEUKIN-2 RECEPTOR BETA REDUCED-BINDING AGONIST

PIPERAZINE DERIVATIVES USEFUL IN HIV THERAPY

HETEROAROMATIC MACROCYCLIC ETHER CHEMOTHERAPEUTIC AGENTS

Benzodiazepine Derivatives as RSV Inhibitors

NOVEL BENZOTHIAZOLE DERIVATIVES

DNA-PK Inhibitor Compounds and Uses Thereof

Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2

PI4-Kinase Inhibitors and Methods of Using the Same

PURE FORMS OF CRYSTALLINE ATICAPRANT

Method of Deodorizing, Antibacterial and Decontamination Using Plasmonic Photocatalyst and Method for Treating Cancer

RADIOLABELED LIPOSOMES AND METHODS OF USE FOR TREATING LEPTOMENINGEAL METASTASES

DISEASE-TARGETED IMAGING AGENTS

PEPTIDE-LINKED DRUG DELIVERY SYSTEM

POTENT ANTI-CANCER CYCLOTIDES

LYMPH DIRECTING PRODRUGS

PHTHALOCYANINE DYE CONJUGATE COMPOSITIONS

MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER

IMMUNOMODULATOR COMPOUNDS AND METHODS OF USE

USE OF TOLL-LIKE RECEPTOR 2 (TLR-2) AGONIST FOR MODULATING HUMAN IMMUNE RESPONSE

VACCINE ADJUVANT, AND PREPARATION METHOD THEREFOR AND USE THEREOF

METHODS OF PREPARATION OF SECRETOMES, AND USES THEREOF

Autoimmune Disease Modulation Protocol

MODIFYING TASTE AND SENSORY IRRITATION OF SMOKELESS TOBACCO AND NON-TOBACCO PRODUCTS

Compositions Containing Cannabis and Hericium Extracts for the Improvement of Mental Health and Treatment of CNS Disorders

METHODS FOR IMPROVING TREATMENT OF EQUINE COLIC BY ADMINISTRATION OF A SYNTHETIC BIOENSEMBLE OR PURIFIED STRAINS THEREOF

A CLINICAL ISOLATED AVIRULENT STRAIN PROTECTS AGAINST WILDTYPE VIRULENT CLOSTRIDIOIDES DIFFICILE INFECTION

TREATING CANCER

THERAPY FOR INHIBITION OF SINGLE-STRANDED RNA VIRUS REPLICATION

COMPOSITIONS FOR USE IN CARTILAGE BREAKDOWN

METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS

ERAVACYCLINE FOR TREATING CANCER

Intravenous Ganaxolone Formulations and Methods of Use in Treating Status Epilepticus and Other Seizure Disorders

COMPOSITIONS FOR LOCAL BONE FORMATION

Method of Treating Obesity with a Luteinizing Hormone Receptor Agonist

METHODS AND PHARMACEUTICAL COMPOSITIONS TO TREAT RESPIRATORY DEPRESSION IN PATIENTS

CDK INHIBITORS

INHIBITORS OF ANTIMOCROBIAL RESISTANCE AND METHOS USING SAME

USE OF SUBLINGUAL DEXMEDETOMIDINE FOR THE TREATMENT OF AGITATION

Methods for Targeting Cancer Cells Using Amino Acids

TREATMENTS FOR CHARCOT-MARIE-TOOTH DISEASE

USE OF A COMBINATION OF SACUBITRIL AND VALSARTAN

Neurodegenerative Disorders And Muscle Diseases Implicating Pufas

METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA

METHODS OF TREATING ISCHEMIC STROKE AT RISK FOR CEREBRAL OR CEREBELLAR EDEMA

NEW USE OF N,N-BIS-2-MERCAPTOETHYL ISOPHTHALAMIDE

A SPHINGOSINE-1-PHOSPHATE RECEPTOR (S1PR) MODULATOR FOR USE IN TREATING A PATIENT SUFFERING FROM ALZHEIMER'S DEMENTIA

COMPOSITIONS AND METHODS FOR MAKING AND USING POLYMER-COATED NANOCAPSULES FOR TARGETED PHARMACEUTICAL AGENT DELIVERY

FLOWPACK WITH COMPOSITION FOR IMPROVED TASTE MASKING OF ACTIVES

FINISHED PHARMACEUTICAL FORM WITH INDIVIDUAL MEDICINE DOSING CAPABILITY (EMBODIMENTS) AND METHODS OF ITS PRODUCTION AND USE

ALTERNATIVELY SPLICED ISOFORM IN CANCER AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B VIRUS (HBV) INFECTION AND HBV-ASSOCIATED DISEASES

INHIBITION OF FOLLISTATIN

GENETICALLY MODIFIED HUMAN STEM CELL EXPRESSING A MUTANT HUMAN CYTOCHROME P450 2B6 PROTEIN AND ITS USE THEREOF IN THE TREATMENT OF CANCER

MONOCLONAL ANTIBODIES FOR THE TREATMENT OF VIRAL INFECTIONS

ANTI-TNFR2 ANTIBODY AND PREPARATION METHOD AND APPLICATION THEREOF

METHODS OF TREATMENT USING A LEPTIN RECEPTOR AGONIST ANTIBODY

ANTI-ALLERGEN ANTIBODIES AND USES THEREOF

BROADLY NEUTRALIZING ANTIBODIES THAT TARGET HIV ENV V3 N-GLYCANS

PHARMACEUTICAL COMPOSITIONS COMPRISING NOVEL CYCLIC PEPTIDES

TRICYCLIC COMPOUNDS AND USES THEREOF

SUBSTITUTED FUSED HETEROAROMATIC BICYCLIC COMPOUNDS AS KINASE INHIBITORS AND THE USE THEREOF

TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS

Novel Inhibitors of Leucine Carboxyl Methyltransferase-1 (LCMT-1) and Methods of Use Thereof

ADENOVIRAL GENE THERAPY VECTORS

RAS INHIBITORS

MESOTHELIN CHIMERIC ANTIGEN RECEPTOR (CAR) AND ANTIBODY AGAINST PD-L1 INHIBITOR FOR COMBINED USE IN ANTICANCER THERAPY

INDOLEAMINE 2,3-DIOXYGENASE BASED IMMUNOTHERAPY

METHODS FOR THE PREVENTION OR TREATMENT OF LEFT VENTRICLE REMODELING

COMPOSITIONS FOR TREATING IMBALANCES OF THE GUT MICROBIOTA

GAMMA POLYGLUTAMATED ANTIFOLATES AND USES THEREOF

Prophylaxis and Treatment of Degraded Cartilage

SURFACE CALR CHEMICAL INDUCERS

USE OF CANNABIDIOL AND CLOBAZAM IN THE TREATMENT OF CHILDHOOD-ONSET EPILEPSY SYNDROMES

NEUROACTIVE STEROID FOR THE TREATMENT OF ALZHEIMER'S DISEASE

PROSTACYCLIN ANALOGUE FORMULATIONS

TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS

TREATMENT AND MANAGEMENT OF AUGMENTATION IN RESTLESS LEGS SYNDROME

COMPOSITIONS AND METHODS FOR THE TREATMENT OF HUNTINGTON’S DISEASE AND HTT PROTEINOPATHIES

METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS

METHODS AND COMPOUNDS FOR RESTORING MUTANT P53 FUNCTION

Method for Treating Inflammatory Dysfunction of the Oral Mucosa

COMPOSITIONS AND METHODS USING A COMBINATION OF FISETIN AND QUERCETIN FOR CELLULAR ENERGY

MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATION OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF

TARGETED NANOPARTICLES AND THEIR USES RELATED TO INFECTIOUS DISEASE

METHOD OF IDENTIFYING A BIOLOGICALLY-ACTIVE COMPOSITION FROM A BIOFILM

METHODS COMPRISING DETECTION OF ADP-HEPTOSE

COMPOSITIONS AND THERAPEUTIC AGENTS FOR MODULATING INFLAMMATORY RESPONSES ON BOTH TUMOR AND IMMUNE CELLS

METHODS OF ASSESSING RISK OF DEVELOPING PROSTATE CANCER

METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISEASE

METHODS FOR TREATING HYPERCHOLESTEROLEMIA

Compositions and Methods for Cancer Immunotherapy

ANTI-CD200R1 ANTIBODIES

ANTI-PAR2 ANTIBODIES

CROSS-SPECIES ANTI-LATENT TGF-BETA 1 ANTIBODIES AND METHODS OF USE

Primary NK CAR Constructs And Methods

Formulated and/or Co-Formulated Liposome Compositions Containing IDO Antagonist Prodrugs Useful in the Treatment of Cancer and Methods Thereof

PHENOXY CARBOXYLIC ACID COMPOUNDS AND MEDICAL USES THEREOF

PROTOCOL FOR MINIMIZING TOXICITY OF COMBINATION DOSAGES AND IMAGING AGENT FOR VERIFICATION

B7H3 ANTIBODY DRUG CONJUGATES

FL118 COMPLEXES FOR TARGETING DDX5, UbE2T or USP2a

LYMPH DIRECTING PRODRUGS

TREATMENT FOR DIABETES IN PATIENTS INAPPROPRIATE FOR METFORMIN THERAPY

COMPOSITIONS AND METHODS COMPRISING ADA-1 FOR WOUND HEALING AND VACCINE ENHANCEMENT

Hyaluronidase Enzyme Formulations for High Volume Administration

METHOD OF PRODUCING PHYSIOLOGICAL AND THERAPEUTIC LEVELS OF NITRIC OXIDE THROUGH AN ORAL DELIVERY SYSTEM

CROSS-LINKED POLYMERIC CHELATORS COMPOSITIONS AND USE THEREOF

SAPONIN-BASED IMMUNOSTIMULANTS, PHARMACEUTICAL COMPOSITION COMPRISING SAID IMMUNOSTIMULANTS, THERAPEUTIC USE THEREOF

GLP-1R MODULATING COMPOUNDS

INHIBITORS OF RLIP76

COMPOUNDS WITH ANTI-TUMOR ACTIVITY AGAINST CANCER CELLS BEARING EGFR OR HER2 EXON 20 INSERTIONS

THERAPEUTIC BENEFIT OF SUBOPTIMALLY ADMINISTERED CHEMICAL COMPOUNDS

Compositions And Methods For Treating Cancer With Calcium Channel Inhibitors

ANTIBODY-DRUG CONJUGATES AND USES THEREOF

GLUCOCORTICOID RECEPTOR MODULATORS TO TREAT PANCREATIC CANCER

COMPOSITIONS AND METHODS USING A COMBINATION OF FISETIN AND QUERCETIN FOR USE IN CARTILAGE DEGENERATION

PETROLATUM-BASED PHMB COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASE

READY-TO-USE KETAMINE PREMIX FORMULATION

METHOD FOR PREPARING MICROCAPSULE, MICROCAPSULE AND COMPOSITION CONTAINING THE SAME

ALLOGENEIC EXTRACELLULAR VESICLES FOR CANCER TREATMENT

FORMULATIONS AND COMPOSITIONS FOR ORTHO- AND/OR RETRO-NASAL DELIVERY AND ASSOCIATED SYSTEMS, METHODS AND ARTICLES

COMPOSITIONS AND METHODS FOR TREATING SKIN PROBIOTIC DEFICIENCY SYNDROME

CONTAINERS WITH SELECTIVE DISSOLVED GAS CONTENT

METHOD AND SYSTEM FOR BRAIN LIQUID BIOPSY AND BRAIN TREATMENT METHOD

METHODS TO DETECT AB PROTEOFORMS AND USE THEREOF

THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER

METHOD OF PROGNOSIS AND FOLLOW UP OF PRIMARY LIVER CANCER

PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING MALIGNANT BREAST CANCER

Crenolanib for Treating FLT3 Mutated Proliferative Disorders Associated Mutations

METHODS AND COMPOSITIONS FOR INFUSION OF TRANSIENTLY ENGRAFTING, SELECTED POPULATIONS OF ALLOGENEIC LYMPHOCYTES TO TREAT CANCER

COMBINATION IMMUNOTHERAPY COMPOSITIONS AND METHODS OF USE THEREOF

MONOCLONAL ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF THAT SPECIFICALLY BINDS TO BCMA, AND USE THEREOF

BIOTIN ORTHOGONAL STREPTAVIDIN SYSTEM

HUMAN ANTIBODIES TO THE GLUCAGON RECEPTOR

Methods and Compositions Comprising Anti-CD3 Antibodies and DYRK1A Inhibitors for Treating Diabetes

ANTI-COMPLEMENT FACTOR H ANTIBODIES

ANTI-SHIGA MONOCLONAL ANTIBODY AND USES THEREOF

DAP12 CONSTRUCTS AND THEIR USE TO ENHANCE DC VACCINES AND IMMUNOTHERAPIES

ARTICLES AND METHODS FOR INHIBITING METHIONINE AMINOPEPTIDASE ACTIVITY

MORPHIC FORMS OF G1T38 AND METHODS OF MANUFACTURE THEREOF

BENZODIAZOLIUM COMPOUNDS AS ENAC INHIBITORS

ACTIVATORS OF EFFECTOR T CELLS

Fused Heterobicyclic Antiviral Agents

SYSTEMS AND METHODS FOR SUPER-RESOLUTION OPTICAL IMAGING TECHNOLOGIES AND/OR NANOSENSOR-DRIVEN PATIENT MONITORING AND/OR TREATMENT

ERYTHROPARVOVIRUS WITH A MODIFIED GENOME FOR GENE THERAPY

NOVEL USE OF ANTICANCER AGENT PRODRUG CONJUGATE

INDIVIDUALIZED CANCER EPITOPES AND METHODS OF USING THE SAME

SET DOMAIN-CONTAINING 2 (SETD2) VACCINE

DRY POWDER FORMULATION OF CAVEOLIN-1 PEPTIDES AND METHODS OF USE THEREOF

METHODS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION

MICROBIOTA RESTORATION THERAPY (MRT) COMPOSITIONS AND METHODS OF MANUFACTURE

AMMONIA OXIDIZING MICROORGANISMS FOR THE REGULATION OF BLOOD PRESSURE

ANTI-ACTIVATED TROP-2 CHIMERIC ANTIGEN RECEPTOR CONSTRUCTS FOR USE IN CANCER THERAPY

TARGETING MODULES AGAINST IL13R-alpha-2 AND/OR HER2 FOR USE IN A METHOD FOR STIMULATING A CHIMERIC ANTIGEN RECEPTOR-MEDIATED IMMUNE RESPONSE IN A MAMMAL

METHODS FOR TREATING ALZHEIMER’S DISEASE

ANTI-INFLAMMATORY PHYTONUTRIENTS FOR USE IN THE TREATMENT OR PREVENTION OF SYNOVITIS

HETEROCYCLIC COMPOUNDS USEFUL FOR TREATMENT OF CANCERS

COMBINATION THERAPIES

INHIBITORS OF CHYMASE FOR USE IN THE SELECTIVE RESOLUTION OF THROMBI IN THROMBOTIC OR THROMBOEMBOLIC DISORDERS

Uses of Bcl-2 Antagonists for Treating Cancer and Diagnostics Related Thereto

COMBINATION TREATMENTS FOR DEPRESSION UTILIZING AN NMDAR ANTAGONIST

METHODS FOR TREATING PTEN-MUTANT TUMORS

METHOD OF PREVENTING OR TREATING HEART FAILURE IN A PATIENT USING (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE-3-CARBOXAMIDE

TREATMENT OR PREVENTION OF CARDIOVASCULAR EVENTS VIA THE ADMINISTRATION OF A COLCHICINE DERIVATIVE

METHODS FOR THE TREATMENT OF DEPRESSION

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING TISSUE CALCIFICATION

TREATMENT OF CANCER AND AUTOIMMUNE DISORDERS USING NANO POLYMERS OF HISTONE DEACETYLASE INHIBITORS

ENTERIC COATING FOR TARGETING THE DUODENUM

SYNTHETIC TRANSDERMAL CANNABIDIOL FOR THE TREATMENT OF FOCAL EPILEPSY IN ADULTS

OPTICAL TRANSMISSION SAMPLE HOLDER AND ANALYSIS, PARTICULARLY FOR HEMOGLOBIN

METHOD FOR DETECTING METABOLIC REPROGRAMING OF CANCER TOWARDS FATTY ACIDS METABOLISM

HEMATOPOIETIC LOSS OF Y CHROMOSOME LEADS TO CARDIAC FIBROSIS AND DYSFUNCTION AND IS ASSOCIATED WITH DEATH DUE TO HEART FAILURE

METHODS FOR AMYOTROPHIC LATERAL SCLEROSIS

FERMENTATION PROCESS INTENDED TO PRODUCE METABOLITES WITH EPIGENETIC PROPERTIES USING BACTERIA EVOLVED IN THE EXTREME CONDITIONS OF SPACE

MUC5AC-TARGETED ANTISENSE OLIGONUCLEOTIDES AND RELATED METHODS FOR MODULATING MUCIN EXPRESSION

TREATMENT OF RENAL CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTI-CANCER AGENT

IL-18BP ANTAGONIST ANTIBODIES AND THEIR USE IN MONOTHERAPY AND COMBINATION THERAPY IN THE TREATMENT OF CANCER

IL-2 VARIANTS WITH REDUCED BINDING TO IL-2 RECEPTOR ALPHA AND USES THEREOF

ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER

METALLOENZYME INHIBITOR COMPOUNDS

COMPOSITIONS AND METHODS FOR THE TREATMENT OF HER2 POSITIVE CANCER

COMPOSITIONS FOR DRG-SPECIFIC REDUCTION OF TRANSGENE EXPRESSION

COMPOSITIONS AND METHODS FOR DELIVERY OF BIOMACROMOLECULE AGENTS

PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM

PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM

PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM

PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM

PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM

METHODS OF TREATING LOCALLY ADVANCED OR METASTATIC BREAST CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

THERAPEUTIC RNA FOR LUNG CANCER

COMBINATION, THERAPEUTIC USES AND PROPHYLACTIC USES

METHODS AND MATERIALS FOR MODULATING T CELL ACTIVATION USING TRAILshort POLYPEPTIDES

Treatment of Myasthenia Gravis with Zilucoplan

STABLE ASCORBIC ACID COMPOSITIONS AND METHODS OF USING THE SAME

CHIMERIC HSV EXPRESSING HIL21 TO BOOST ANTI-TUMOR IMMUNE ACTIVITY

POSTBIOTIC PREPARATION FOR PREVENTING OR TREATING OBESITY

DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM CELLS

T-CELL TARGET DISCOVERY

MENIN-MLL INHIBITORS FOR THE TREATMENT OF CANCER

METHOD FOR PROMOTING ELONGATION OF LONG BONE DURING CHILDHOOD TO ADOLESCENCE BY GPER-1 ACTIVATION VARIANT

Increasing Cancer Cells' Sensitivity to Tumor Treating Fields (TTFields) by Inhibiting IL11 Activity

METHODS FOR TREATING HEART DISEASES

METHODS OF TREATING ALLOGRAFT REJECTION

FORMULATION FOR SOFT ANTICHOLINERGIC ANALOGS

AGENT FOR PROMOTING ODONTOBLAST PROPAGATION AND DIFFERENTIATION